๐๏ธ Verified NIH Record โข Updated 2026-05-01
Patient Related Outcomes for Gynecologic Radiation Oncology (NCT04753086)
LCCC 2052: Patient Related Outcomes for Gynecologic Radiation Oncology (PRO-GRO)
๐ต Active, Not Recruiting Interventional Protocol ๐ Observational Clinical Research Sponsor: UNC Lineberger Comprehensive Cancer Center
๐ฉบ Plain-English Summary (8th-Grade Level)
The goal of this study is to see if it is feasible to use electronic questionnaires to measure patient related outcomes before, during, and after radiation for gynecologic cancer in a high-volume radiation oncology clinic.
Who can join: Review the eligibility criteria below.
Location: University of North Carolina at Chapel Hill, Department of Radiation Oncology โ Chapel Hill, North Carolina
Age range: 18 Years
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (1 Sites)
- University of North Carolina at Chapel Hill, Department of Radiation Oncology โ Chapel Hill, North Carolina
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Gynecologic Cancer
- Journey Ahead: Enhancing Coping and Communication for Women Diagnosed With Gynecological Cancer โ New Brunswick, New Jersey
- Optimizing Brachytherapy Application and Delivery With MRI Guidance for Gynecologic Cancer โ Boston, Massachusetts
- Feasibility Study: IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment) Intervention โ Houston, Texas
- Impact of Cultural and Linguistic Backgrounds on Patient Care and Experience of Women With Gynecologic Malignancies โ Toronto, Ontario
- Intraperitoneal FT536 in Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer โ Minneapolis, Minnesota
Explore by condition: All Gynecologic Cancer clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.